This inventor holds 1 USPTO granted patent. Top assignee: The Queens's Medical Center. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Andrea Flieg: Innovator in TRPM5 Modulation
Introduction
Andrea Flieg is a notable inventor based in Honolulu, HI (US). She has made significant contributions to the field of ion channel research, particularly through her innovative methods for screening TRPM5 modulators. Her work has implications for understanding and potentially treating various physiological conditions.
Latest Patents
Andrea Flieg holds a patent titled "Methods of screening for TRPM5 modulators." This invention relates to methods useful in identifying molecules that bind to TRPM5, which modulate TRPM5 ion channel activity, and/or alter the expression of TRPM5 within cells. The TRPM5 channels described in her patent contain TRPM5 polypeptides, which are encoded by TRPM5 nucleic acids. The ion channels are preferably formed in HEK-293 cells from one or more novel TRPM5 polypeptides, exhibiting unique TRPM5 properties.
Career Highlights
Andrea Flieg is associated with The Queen's Medical Center, where she applies her expertise in ion channel research. Her work is pivotal in advancing the understanding of TRPM5 channels and their potential therapeutic applications.
Collaborations
Andrea collaborates with Reinhold Penner, contributing to the advancement of research in the field of TRPM5 modulation.
Conclusion
Andrea Flieg's innovative work in TRPM5 modulation highlights her significant role in advancing scientific research and potential therapeutic applications. Her contributions are essential for the ongoing exploration of ion channel functionality and its implications in health.